Skip to main content

View full-text article in PMC

. 2019 Nov 15;11(11):6754–6774.

Table 1.

Relationship between miR-136-5p expression and clinicopathological features from TCGA

Clinicopathological feature		N	miR-136-5p expression of TCGA database

			M ± SD	T	P
Tissue	Adjacent non-carcinomic tissues	59	3.4937±0.9704	-5.943^a	<0.001^a
Tissue	TC	495	2.6547±1.4021
Gender	Male	131	2.5431±1.3393	-1.011^a	0.312^a
Gender	Female	358	2.6880±1.4296
Pathologic tumor grade	Stage I-II	325	2.4396±1.2757	-4.552^a	<0.001^a
Pathologic tumor grade	Stage III-IV	162	3.081±1.5513
Age (years)	>50	207	2.8134±1.4702	2.193^a	0.029^a
Age (years)	≤50	282	2.5287±1.3433
TNM stage	T1+T2	303	2.4844±1.2966	-3.179^a	<0.001^a
TNM stage	T3+T4	184	2.9152±1.5352
Lymph node metastasis	No	221	2.4402±1.3914	4.123^a	<0.001^a
Lymph node metastasis	Yes	220	2.9822±1.3687
Distant metastasis	No	273	2.8815±1.4009	4.123^a	<0.001^a
Distant metastasis	Yes	9	2.1385±2.3264
Race	White	320	2.7705±1.3877	1.225^b	0.295^b
	African American	27	2.3961±1.5205
	Asian	52	2.9109±1.4001

^a

Student’s paired t-test;

^b

One-way analysis of variance (ANOVA).